Rheumatology (Oxford). 2010 Mar;49(3):490-500. Epub 2009 Dec 16.
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.
Am J Respir Crit Care Med. 2010 Apr 15;181(8):851-61. Epub 2010 Jan 7.
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jaïs X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A, Sitbon O, O'Callaghan DS, Simonneau G, Soubrier F, Humbert M.
Respir Med. 2010 Jul;104 Suppl 1:S74-80. Epub 2010 Apr 24.
Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension.
O'Callaghan DS, Savale L, Jaïs X, Natali D, Montani D, Humbert M, Simonneau G, Sitbon O.
Eur J Cardiothorac Surg. 2010 Sep;38(3):277-84. Epub 2010 Apr 3.
Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients.
Fadel E, Mercier O, Mussot S, Leroy-Ladurie F, Cerrina J, Chapelier A, Simonneau G, Dartevelle P.
Ann Rheum Dis. 2010 Jul;69(7):1360-3. Epub 2010 May 14.
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group.
Avouac J, Kowal-Bielecka O, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Distler O, Furst DE; EPOSS Group
Eur Respir J. 2010 May;35(5):945-8.
The changing face of respiratory physiology: 20 years of progress within the ERS: Clinical Physiology and Integrative Biology Assembly contribution to the celebration of 20 years of the ERS.
Calverley P, Miserocchi G, Puente Maestu L, Aliverti A, De Backer W, Andreas S, Humbert M.
Curr Opin Pulm Med. 2010 May;16 Suppl 1:S43-6.
Perspective on the optimal endpoints for pulmonary arterial hypertension trials.
Rubin L, Simonneau G.
Curr Opin Pulm Med. 2010 May;16 Suppl 1:S21-6.
Assessing effectiveness of pulmonary arterial hypertension therapies in daily practice.
Sitbon O, Hoeper MM, Simonneau G.
Curr Opin Pulm Med. 2010 May;16 Suppl 1:S11-9.
Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
Galiè N, Simonneau G, Barst RJ, Badesch D, Rubin L.
Curr Opin Pulm Med. 2010 May;16 Suppl 1:S1-9.
Endpoints in pulmonary arterial hypertension: the role of clinical worsening.
Peacock A, Keogh A, Humbert M.